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Abstract 
Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic cancer, whose pathologic 
features are indistinguishable from those of hepatocellular carcinoma. About thirty 
cases, nearly half of which occurring in the lung, have been described in patients with a 
normal liver. No imaging features are typical enough to allow a correct diagnosis. 
A localization of HAC in the soft tissues of the shoulder with invasion of the scapula in a 
woman without other symptoms is reported in this paper; soft-tissue HACs have never 
been described to date. An associate pulmonary HAC was eventually found in this 
patient. 
 
Introduction 
Hepatoid adenocarcinoma (HAC) is a very unusual histological type of primitive 
extrahepatic cancer. HAC can virtually never be distinguished at pathologic examination, 
on the basis of morphology alone, from hepatocellular carcinoma, whose gross and 
microscopic features (sheet-like or trabecular proliferation of neoplastic cells with 
abundant, eosinophilic cytoplasm, arranged in a solid pattern with sinusoid-like spaces 
lined by endothelium) it shares [1]. A final differential diagnosis can be obtained, in most 
cases, only through immunohistochemistry [2]. As possible origins of this tumor, cancer 
arising from ectopic liver cells embedded in the organs where HAC develops and 
neoplastic transformation of persistent germ cells or of nonhepatic epithelium capable of 
multipotential differentiation have been hypothesized [1]. 
The majority of HACs produce alpha-fetoprotein, whose plasma levels may be very 
high; however, some cases have been described in whom alpha-fetoprotein was normal. 
HAC occurs in patients with no history of hepatic disease, alcoholism or addiction to 
other potential sources of hepatic damage; their livers demonstrate no functional or  
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morphological abnormalities. Blood samples do not reveal elevated levels of hepatic 
enzymes, and imaging examinations fail to detect any major alteration as to volume and 
structure of the liver, except in the cases where hepatic metastases develop. If a liver 
specimen is obtained, normal features are demonstrated at pathology. 
No more than 30 HACs, to our knowledge, have been reported to date. Twelve of 
them, in most cases leading to a poor prognosis, occurred in the lungs [1–8]; moreover, 2 
histologically inhomogeneous pulmonary cancers have been described containing 
scattered hepatoid foci [9, 10]. The majority of extrapulmonary HACs occur in the 
stomach [11], while 1 or 2 cases each were found in the mediastinum, esophagus, 
gallbladder, pancreas, ampulla of Vater, renal pelvis, bladder, endometrium, ovary, and 
testicle [12–15]. We were not able to find, in the English literature, any published paper 
reporting soft-tissue localizations of HAC. 
Case Report 
A 68-year-old nonsmoker, nonalcoholic woman, who did not report any exposition to agents 
inducing liver damage and who had no history of hepatic or pulmonary disease nor of any kind of 
cancer, underwent a conventional radiography of her left shoulder, complaining of localized pain. An 
ill-defined radiolucent area (fig. 1a), expression of osteolysis, was found within the scapula. A magnetic 
resonance examination of the shoulder was therefore performed a few days later, which demonstrated a 
large (8 × 5.5 × 4.5 cm) smooth-margined mass, moderately inhomogeneous and fairly enhancing after 
intravenous administration of paramagnetic contrast medium, infiltrating the scapular girdle both in its 
muscular (mainly in the supraspinatus muscle) and in its bony component (fig. 1b, c), confirming the 
radiographic finding and indicating a malignant soft-tissue mass with adjacent bone invasion. 
Ultrasound-guided fine-needle aspiration biopsy of the soft-tissue mass showed malignant cells in a 
trabecular pattern containing biliary thrombi (fig. 2); these features were considered by the pathologist 
a clue to the diagnosis of a soft-tissue localization of a hepatocellular carcinoma. 
No significant abnormalities were found in blood samples: in particular, hepatic enzymes, the other 
liver function parameters and the serum level of alpha-fetoprotein (2.4 ng/ml) were all normal. 
Moreover, at both ultrasound and computed tomography (CT) examinations the liver had normal size 
and margins, with normal hepatic vessels; no focal lesions were detected and echotexture and density 
were homogeneous. A 4.5 × 4 × 4 cm solid, partly inhomogeneous mass with pleural adhesion was, 
however, found at CT in the upper lobe of the left lung (fig. 3), without regional lymphadenopathies nor 
further localizations. Pathologic examination of a CT-guided biopsy of the pulmonary mass revealed 
hepatocellular carcinoma-like neoplastic tissue whose pattern was undistinguished from the specimen 
obtained in the soft-tissue mass. A double localization of HAC, in the lung and in the soft tissues of the 
shoulder, was therefore diagnosed, the latter presumably being a metastasis from the former. 
The patient underwent chemotherapy. Fifteen months after the diagnosis, she is alive and symptom-
free; the size of both the soft-tissue and the pulmonary lesions has significantly reduced and no further 
localizations have appeared in any other organ or in the lymph nodes. 
Discussion 
Due to its low prevalence, HAC is never taken into consideration when an extrahepatic 
mass is found at imaging or endoscopy. One might suspect that in some cases of HAC the 
correct diagnosis is not achieved, particularly in the elderly or in patients with severe 
underlying disease, in whom the diagnostic workout sometimes concludes with a generic 
cytological ascertainment of the presence of malignant cells within a lesion. 
In addition to its rarity, HAC may be underdiagnosed because of the absence of 
unequivocal imaging features. In the only paper published in the radiological literature on 
this topic [8] some CT characteristics have been identified as relatively common to HACs, 
whatever their localization. According to these authors, HACs are usually large-sized  
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tumors, with the same density of the normal liver at baseline scan (the presence of 
necrotic areas, however, often makes masses appear inhomogeneous), and moderately 
enhance after intravenous iodinated contrast medium administration; invasion of 
adjacent anatomical landmarks (such as the pleural surface for pulmonary HACs), 
regional lymphadenopathies and distant metastases are frequently observed. In this series, 
however, only one of the tumors was localized in the lung, and none of the imaging 
features described is considered by the authors themselves typical enough to direct the 
diagnosis. 
The pulmonary HAC we observed (fig. 3) shares some of these CT characteristics 
(large size, slight inhomogeneity, adhesion to the pleura), its features being nevertheless 
largely nonspecific. Similar characteristics as to volume, structure and invasion of the 
adjacent tissues (fig. 1b, c) can be identified in the shoulder mass, which makes our case 
unique: to our knowledge soft-tissue HACs have never been previously described, either 
isolated or in association with involvement of the lung, the stomach or other organs. 
Moreover, serum alpha-fetoprotein in our patient was normal, which did not aid the 
diagnosis. On the other hand, to date this patient has experienced a better prognosis than 
the average of her counterparts. 
In conclusion, we suggest that HAC – although rare – should be included in the 
differential diagnosis when, in patients with a normal liver (especially if serum alpha-
fetoprotein is raised), a mass similar in histology to hepatocellular carcinoma is found at 
any extrahepatic location. 
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Fig. 1. Conventional frontal radiographic view of the left shoulder (a) shows an ill-defined scapular 
radiolucent area, 3 cm in diameter (arrows), due to erosion from soft-tissue localization of HAC. Axial 
MRI scans demonstrate an 8-cm well-defined partly inhomogeneous solid mass in the soft tissues of the 
left shoulder (asterisks), showing high signal intensity in a fat-suppressed T1-weighted sequence (b) and 
moderate enhancement after intravenous administration of paramagnetic contrast medium (c). 
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Fig. 2. Fine-needle aspiration biopsy of the soft-tissue mass (hematoxylin-eosin stain). Very numerous 
neoplastic epithelial cells arranged in trabecular and pseudoacinar patterns, associated with biliary 
thrombi. The cytological findings are typical of a hepatocellular carcinoma. 
 
 
 
Fig. 3. (a, b). Multidetector (16-row) CT scans. 4.5 cm solid, partly inhomogeneous mass with pleural 
adhesion in the upper lobe of the left lung. 
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